Hims & Hers Faces Profitability Squeeze After Novo Nordisk Settlement
Hims & Hers resolves legal dispute with Novo Nordisk for weight-loss drug rights, but the shift to branded…
Hims & Hers Stock Soars on Strategic Pivot with Novo Nordisk
Hims & Hers settles patent litigation, will now sell Novo Nordisk’s Ozempic and Wegovy. The telehealth firm forecasts…
Hims & Hers Stock Soars on Strategic Pivot and Novo Nordisk Alliance
Hims & Hers partners with Novo Nordisk for FDA-approved GLP-1 drugs, resolving legal risks and fueling a 40%…
Hims & Hers abandons plan for cheaper Wegovy knockoff after FDA warning
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy…
Hims & Hers Stock Soars on Strategic Pivot with Novo Nordisk
Hims & Hers abandons compounding for a direct Novo Nordisk deal, restoring access to Wegovy and sending its…
Novo Nordisk surges as Hims & Hers ditches copycat weight-loss pill
Shares of Danish pharmaceuticals firm Novo Nordisk surged on Monday after US telehealth company Hims & Hers said…
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting…